Dosage Forms

Articles

The companies will use GeoVax’s vaccine technology to develop malaria vaccine candidates.

GeoVax, Leidos Expand Collaboration to Include Malaria Vaccines

The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac partner to develop a transportable mRNA vaccine manufacturing platform.

CEPI, CureVac Partner to Develop mRNA Vaccine Manufacturing Platform

A project conducted by research institute CEA-Leti led to the development of a new HIV vaccine approach based on engineered lipid nanoparticles.

New Vaccine for HIV Using Lipid-Nanoparticle Technology

India’s Bharat Biotech is set to acquire GlaxoSmithKline’s Chiron Behring Vaccines, a World Health Organization-prequalified global manufacturer of rabies vaccines.

Bharat Acquires GSK’s Chiron Behring Vaccines

The companies will use a $4.4-million grant from the National Institute of Allergy and Infectious Diseases to discover sustainable alternatives to shark squalene to use as vaccine adjuvants.

Amyris, IDRI to Engineer Molecules for Vaccine Adjuvant Applications

Researchers used magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus.

Micromotors Deliver Oral Vaccines

Merck & Co.’s V920 (rVSV-ZEBOV) vaccine is expected to pave the way for the development of vaccines for emerging infectious disease with unpredictable disease incidence or geography, according to data and analytics company, GlobalData.

Merck’s Experimental Vaccine Marks Turning Point in Ebola Outbreak Prevention

Sanofi’s Adacel (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis [Tdap] vaccine adsorbed) is approved for a repeat dose in people 10 through 64 years of age, 8 years or more after the first vaccination.

FDA Approves Expanded Use of Sanofi’s Tdap Vaccine

The company has brought a second stream of high-throughput GMP peptide manufacturing online.